Resveratrol Decreases CD45+ CD206- Subtype Macrophages in LPS-induced Murine Acute Lung Injury by SOCS3 Signalling Pathway.

Lu Hu,Zhihong Chen,Liyang Li,Zhilong Jiang,Lei Zhu
DOI: https://doi.org/10.1111/jcmm.14680
2019-01-01
Journal of Cellular and Molecular Medicine
Abstract:Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) are life-threatening condition in critically ill patients. Resveratrol (Res), a natural polyphenol, has therapeutic effect in animal model with ALI; however, whether Res attenuates ALI through modulation of macrophage phenotypes in the animal model remains unknown. We in this study treated LPS-induced murine ALI with 30 mg/kg Res and observed significantly reduced severity of ALI in the Res-treated mice 48 hours after Res treatment. Neutrophil infiltrates were significantly reduced, accompanied with lower infiltration of CD45(+)Siglec F- phenotype macrophages, but higher population of CD45(+)Siglec F+ and CD45(+)CD206(+) alternatively activated macrophages (M2 cells) in the Res-treated mice with ALI. In addition, the expression of IL-1beta and CXCL15 cytokines was suppressed in the treated mice. However, Res treatment in mice with myeloid cell-restricted SOCS3 deficiency did not significantly attenuate ALI severity and failed to increase population of both CD45(+)Siglec F+ and CD45(+)CD206(+) M2 subtype macrophages in the murine ALI. Further studies in wild-type macrophages revealed that Res treatment effectively reduced the expression of IL-6 and CXCL15, and increased the expression of arginase-1, SIRT1 and SOCS3. However, macrophages' lack of SOCS3 expression were resistant to the Res-induced suppression of IL-6 and CXCL15 in vitro. Thus, we conclude that Res suppressed CD45(+)Siglec F- and CD45(+)CD206(-) M1 subtype macrophages through SOCS3 signalling in the LPS-induced murine ALI.
What problem does this paper attempt to address?